As of 2025-07-06, the Fair Value of Vivoryon Therapeutics NV (VVY.AS) is -3.94 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.47 EUR, the upside of Vivoryon Therapeutics NV is -368.35%.
With the market price of 1.47 EUR and our fair value calculation, Vivoryon Therapeutics NV (VVY.AS) is not a good investment. Investing in VVY.AS stocks now will result in a potential loss of 368.35%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -16.51 | -12.66 | -28.16 | -28.34 | -20.57 | -21.25 |
| YoY growth | -111.04% | 23.35% | -122.49% | -0.66% | 27.43% | -36.68% |
| Market Cap (mil) | 38.32 |
| P/E | |
| Forward P/E |
| EPS | -0.79 |
| Avg earnings growth rate | -36.68% |
| TTM earnings | -20.57 |